RE: US CANCER RESEARCH INSTITUTE TUNEOVER30 Nov 2023 10:39
I have also added this morning albeit a fairl small amount. The herd will revisit this once we get a sniff of blue. 10 mil mcap is only 18p for what news we have had I’d say tht is ludacrusly conservative
If I had taken your advice on most stocks I’d have lost thousands, currently I haven’t lost anything here and I am sure most will agree that wpnt be the case in weeks to come.
Funny as the pumpers at FAB earlier in the week are now here spouting the same 4p 6p 10p. Looks like it’s going the other way and they will be over at FAB AGAIN
Not true the market had less than 30 mins to process, the price dropped back to under 2 before retreating a little. There was a lot of buying going on from opportunists today will see t he real answer, will it take the beast or will it drop like a stone
Plenty rampers over there that’s for sure only there isn’t anything to ramp. At least we have a deal with the worlds largest cancer researcher who are prepared to fund. And don’t listen to those suggesting cash is low, it was started the raise in May would suffice until Nov 24! That’s right, even with the market difficulties and increased costs there’s still plenty room to manovuer!
Only spiked if you were short sighted enough to sell and chase new rainbows. This will move up again once they have gone, and looks like they already have judging by some of the posters who have left and shown up
NH, all points must be considered and Pumpky has some valid concerns. IMO on AIM the risk reward is part of the assessment which can be very subjective depending on your pov. It is difficult to value these types of assets but from my side I look at what peers are offering, their balance sheets and where they are in terms of delivering their shareholder promises. The general consensus is that most are either hugely over valued in comparison or they are valued on a potential basis which would mean we are undervalued.